Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices 26687 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0969; Docket No. CDC–2018– 

0044] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Monitoring Changes in Attitudes 

and Practices among Family Planning 

Providers and Clinics. This project seeks 

to obtain information on changes in 

attitudes and practices among family 

planning providers and clinics in the 

United States related to 

recommendations from national 

contraception guidelines. 

DATES: CDC must receive written 

comments on or before August 7, 2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0044 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Leroy A. 

Richardson, Information Collection 

Review Office, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, MS–D74, Atlanta, Georgia 

30329; phone: 404–639–7570; Email: 

omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Monitoring Changes in Attitudes and 

Practices among Family Planning 

Providers and Clinics (OMB No. 0920– 

0969, exp. 5/31/2014)—Reinstatement 

with Change—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Division of Reproductive Health 

(DRH) at the Centers for Disease Control 

and Prevention (CDC) and the HHS 

Office of Population Affairs (OPA) 

develop and disseminate guidance to 

improve the use of contraception and 

the delivery of quality family planning 

services. The U.S. Medical Eligibility 

Criteria for Contraceptive Use (US 

MEC), the first national guidance on 

family planning containing evidencebased recommendations for the safe use 

of contraceptive methods for women 

and men with specific characteristics 

and medical conditions, was first 

published by the CDC in June 2010. The 

US Selected Practice Recommendations 

for Contraceptive Use (US SPR), which 

provides guidance on how to use 

contraceptive methods safely and 

effectively once they are deemed to be 

medically appropriate, was first 

published by the CDC in June 2013. The 

US MEC and US SPR were updated after 

review of the scientific evidence and 

consultation with national experts in 

family planning; the revised US MEC 

and US SPR were published in August 

2016. Providing Quality Family 

Planning Services (QFP), which 

provides evidence-informed 

recommendations to improve client care 

and service delivery infrastructure to 

support the provision of quality family 

planning services to women and men of 

reproductive age in the United States, 

was published by CDC and OPA in 

April 2014. The US MEC, US SPR, and 

QFP have been widely disseminated to 

health care providers and other 

constituents via professional 

organizations, federal program grantees, 

scientific and programmatic meetings, 

scientific manuscripts, online resources, 

and other avenues. 

To monitor changes in attitudes and 

practices regarding provision of 

contraception among family planning 

providers and clinics, we initiated a 

multi-phase assessment. In 2009–2010, 

CDC carried out the first phase of the 

assessment, collecting information 

before the release of the US MEC (OMB 

No. 0920–0008). In 2013–2014, CDC, in 

collaboration with OPA, carried out the 

second phase of the assessment, 

collecting information before the release 

of the US SPR and QFP (OMB No. 0920– 

0969). These information collections 

provided useful knowledge about 

attitudes and practices of family 

planning providers. CDC and OPA used 

the findings to develop educational 

materials and opportunities for health 

care providers. 

In 2018, in collaboration with OPA, 

CDC plans to request a reinstatement of 

OMB No. 0920–0969, ‘Monitoring 

Changes in Attitudes and Practices 

among Family Planning Providers and 

Clinics’ to carry out the third phase of 

the assessment. As in the previous 

phases, the information collection will 

allow CDC and OPA to improve family 

planning-related practice by: (1) 

Understanding the current use of 

contraception guidance in practice, 


amozie on DSK3GDR082PROD with NOTICES1
26688 Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices 

including awareness and use of the US 

MEC, US SPR and QFP; (2) describing 

current attitudes and practices among 

family planning providers and clinics 

related to recommendations included in 

the US MEC, US SPR, and QFP and 

assessing changes from previous data 

collections; and (3) identifying training 

needs in use of guidance and family 

planning service delivery (e.g., provider 

tools, continuing education modules). 

As in previous phases of data 

collection, CDC plans to administer 

surveys to private and public sector 

family planning providers and clinic 

administrators in the United States. The 

design, methodology, and analytic 

approach that CDC plans to implement 

are based on methods previously 

approved for the 2013–2014 survey, 

with different instruments being 

administered to providers and clinic 

administrators. Minor changes to survey 

content will be made to eliminate 

unnecessary questions, add new 

questions of interest, and improve 

formatting, usability, and data quality. 

OMB approval is requested for one year. 

The estimated burden per response for 

providers is 15 minutes and has not 

changed since the previous OMB 

approval. The estimated burden per 

response for administrators will be 

reduced from 40 minutes to 35 minutes. 

The total burden for participants is 

estimated at 1,916 hours. Participation 

is voluntary and there are no costs to 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Office-based physicians (private sector).2018–2019 Survey of Health Care 

Providers about Family Planning 

Attitudes and Practices.

1,000 1 15/60 250 

Title X clinic providers (public sector) 2018–2019 Survey of Health Care 

Providers about Family Planning 

Attitudes and Practices.

1,000 1 15/60 250 

Non-Title X publicly funded clinic 

providers (public sector).

2018–2019 Survey of Health Care 

Providers about Family Planning 

Attitudes and Practices.

1,000 1 15/60 250 

Title X clinic administrators (public 

sector).

2018–2019 Survey of Administrators 

of Health Centers that Provide 

Family Planning.

1,000 1 35/60 583 

Non-Title X publicly funded clinic administrators (public sector).2018–2019 Survey of Administrators 

of Health Centers that Provide 

Family Planning.

1,000 1 35/60 583 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,916 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–12373 Filed 6–7–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–18ACN; Docket No. CDC–2018– 

0042] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Undetermined cause of Serratia 

marcescens infections—Multiple States, 

2018. The goal of this investigation is to 

identify potential risk factors leading to 

an outbreak of Serratia marcescens 

infections among U.S. healthcare 

patients. Data will be used to identify a 

cause of the infections and prevent 

additional events from occurring. 

DATES: CDC must receive written 

comments on or before August 7, 2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0042 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Leroy A. 

Richardson, Information Collection 

Review Office, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, MS–D74, Atlanta, Georgia 

30329; phone: 404–639–7570; Email: 

omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 


amozie on DSK3GDR082PROD with NOTICES1